Sort
82,697 grants matching “vaccine development”
Revolutionary Eilat-based Chikungunya Vaccine Vector
$825,842Tian Wang · University Of Texas Med Br Galveston · R01 · FY2021 · AI
A Multicomponent Anthrax Vaccine using Phage T4 Display
$825,803Venigalla B. Rao · Catholic University Of America · U01 · FY2006 · AI
Non-human primate models of malarial anemia
$825,798Mary R Galinski · University Of Notre Dame · P01 · FY2008 · HL
Immune epigenetic biomarkers of survival in glioma epidemiology
$825,775John K. Wiencke · University Of California, San Francisco · R01 · FY2017 · CA
ALLERGEN GENE VACCINATION--PRINCIPLES AND APPLICATIONS
$825,740University Of California San Diego · P01 · FY2001 · AI
Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals
$825,707Shelly J Krebs · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2024 · AI
Regulatory dendritic cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$825,391Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
$825,382Andrew McGuire · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$825,277Arash Grakoui · Emory University · R01 · FY2018 · AI
Structure and Dynamics of the SARS-CoV-2 Spike Protein
$825,206Walther H Mothes · Yale University · R01 · FY2023 · AI
Fluorescent nanofoldamers for multiplex flow cytometry
$825,109Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2022 · GM
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
$825,106Mauricio De Aguiar Martins · University Of Florida · R01 · FY2023 · HD
Heritable immunization of the white-footed mouse reservoir of Lyme disease
$825,096Kevin Esvelt · Massachusetts Institute Of Technology · R01 · FY2025 · AI
Task A63: Evaluation of therapeutics and vaccines in mouse models of dengue virus
$825,058David Beasley · University Of Texas Med Br Galveston · N01 · FY2023 · AI
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
$825,050Cameron F Abrams · Drexel University · R01 · FY2023 · AI
A Randomized Phase I Clinical Trial of HydroVax-YFV, a Novel Inativated Yellow Fever Vaccine
$825,048Ian James Amanna · Najit Technologies, Inc. · U44 · FY2023 · AI
Novel Interventions Against HPV-associated Neoplasia
$825,000Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2009 · CA
Comprehensive antigenic mapping of the human anti-peanut IgE antibody response
$824,999Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2021 · AI
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$824,985Michael R. Farzan · Boston Children'S Hospital · R01 · FY2024 · AI
Human Genes that Influence HIV-1 Replication, Pathogenesis, and Immunity in IVDUs
$824,937Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · DP1 · FY2015 · DA
Prostate Section
$824,926Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Leveraging PfCRT Structure to Discern Function and Predict Emergence of Drug-Resistant Malaria
$824,925Filippo Mancia · Columbia University Health Sciences · R01 · FY2025 · AI
Immune Control and Immune Evasion during Acute Hepatitis C Virus Infection
$824,922Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2007 · AI
Glycan modification, CD4 independence, and Env immunogenicity
$824,905Shiu-Lok Hu · University Of Washington · R01 · FY2011 · AI
Eliciting Broadly Neutralizing Antibody Responses against HIV-1 Fusion Peptide Epitope by AB Toxin B Subunit-Based Immunogens
$824,847Xiangpeng Kong · New York University School Of Medicine · R01 · FY2025 · AI